Zacks Research Predicts Health In Tech Q3 Earnings

Key Points

• Zacks Research expects Health In Tech to report a Q3 2026 loss of $0.03 per share, with projected losses of $0.02 per share in Q4 and $0.12 for full-year 2026.
• Analyst sentiment is mixed: Maxim Group maintains a “Buy” rating despite lowering its price target to $3, while Weiss Ratings reiterated a “Sell” rating. MarketBeat reports a consensus “Moderate Buy” rating and a $3.50 average target price.
• Health In Tech recently missed its quarterly EPS estimate, reporting a $0.04 loss per share versus the expected $0.03 loss, while generating $8.06 million in revenue. Shares opened at $0.97, near the lower end of their 52-week range.

Health In Tech, Inc. (NASDAQ:HIT - Free Report) - Investment analysts at Zacks Research issued their Q3 2026 earnings per share (EPS) estimates for Health In Tech in a research report issued on Wednesday, August 26th. Zacks Research analyst M. Marin anticipates that the company will post earnings per share of ($0.03) for the quarter. Zacks Research also issued estimates for Health In Tech's Q4 2026 earnings at ($0.02) EPS and FY2026 earnings at ($0.12) EPS.

Other research analysts have also recently issued reports about the stock. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Health In Tech in a research report on Tuesday, June 30th. Maxim Group dropped their price objective on shares of Health In Tech from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Health In Tech presently has a consensus rating of "Moderate Buy" and an average target price of $3.50.

Health In Tech Stock Up 0.8%

HIT stock opened at $0.97 on Wednesday. The business has a fifty day simple moving average of $1.05 and a 200-day simple moving average of $1.24. The company has a market cap of $63.44 million, a price-to-earnings ratio of -13.83 and a beta of 2.82. Health In Tech has a 52 week low of $0.85 and a 52 week high of $4.02.

Health In Tech (NASDAQ:HIT - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The firm had revenue of $8.06 million during the quarter.

Institutional Investors Weigh In On Health In Tech

Large investors have recently modified their holdings of the stock. Jane Street Group LLC lifted its position in Health In Tech by 307.9% during the 4th quarter. Jane Street Group LLC now owns 50,648 shares of the company's stock worth $81,000 after acquiring an additional 38,230 shares in the last quarter. State Street Corp grew its position in Health In Tech by 195.3% in the fourth quarter. State Street Corp now owns 62,900 shares of the company's stock valued at $100,000 after acquiring an additional 41,600 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Health In Tech in the third quarter valued at approximately $45,000. Millennium Management LLC purchased a new stake in shares of Health In Tech during the third quarter valued at approximately $85,000. Finally, XTX Topco Ltd purchased a new stake in shares of Health In Tech during the fourth quarter valued at approximately $203,000.

Health In Tech Company Profile

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source